Company Filing History:
Years Active: 2022
Title: **Inventor Zhongli Bao: Pioneering Advances in Recombinant Human Insulin**
Introduction
Zhongli Bao, an innovative inventor based in Chino Hills, California, has made significant contributions to the field of biopharmaceuticals. His work focuses on the development of highly purified recombinant human insulin, a crucial medication for diabetes management. With a strong commitment to enhancing drug purity and effectiveness, Bao's patent showcases his expertise and dedication to improving healthcare solutions.
Latest Patents
Bao holds a notable patent for "Highly purified recombinant human insulin (RHI) API and methods of producing the same." This patent outlines methods for producing RHI with an impressive purity of 99.0% (w/w) or greater. Additionally, it specifies that the total impurity should be 0.8% (w/w) or less, with an impurity C of 0.1% (w/w) or less. Such specifications ensure the development of a safe and effective insulin product, which is vital for patients relying on precise dosages.
Career Highlights
Zhongli Bao works at Amphastar Pharmaceuticals, Inc., a prominent company in the pharmaceutical industry. His background in biochemistry and pharmaceutical sciences has enabled him to contribute effectively to the development of essential medications. Bao's focus on quality and innovation in drug formulation has set a benchmark within the industry for producing high-quality biopharmaceuticals.
Collaborations
Throughout his career, Bao has collaborated with talented colleagues such as Jie Fei Ding and Aili Bo. These partnerships have allowed for the exchange of ideas and methodologies, fostering a collaborative environment that enhances research and development efforts. Working alongside other experts in the field has positioned Bao and his team for continued success in their endeavors.
Conclusion
Zhongli Bao's contributions to the field of recombinant human insulin exemplify the importance of innovation in pharmaceuticals. By focusing on producing highly purified insulin, Bao is making a positive impact on the lives of individuals with diabetes. As he continues to work with esteemed colleagues at Amphastar Pharmaceuticals, Inc., the advancements in drug formulation and purity promise to benefit healthcare for years to come.